Calla Lily Clinical Care

Drug Delivery · London, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of women-specific drug-delivery systems designed to improve patient outcomes. Calla Lily Clinical Care is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $14.4 million in Jan 2025. It has raised $6.9 million across 1 recorded round; the latest was an accelerator round in Mar 2025.

Last reported valuation
$14.4M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
Accelerator/Incubator
Mar 2025
What is Calla Lily Clinical Care worth?
$14.4Mlast reported valuation · Oct 2026

Calla Lily Clinical Care's last reported valuation, Jan 2025. Nothing priced has surfaced since.

Free account
More of Calla Lily Clinical Care with a free account
  • ·Watch Calla Lily Clinical Care: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Calla Lily Clinical Care funding history

1 rounds
DateRoundRaisedPost-money
Mar 2025Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

Calla Lily Clinical Care valuation

Calla Lily Clinical Care's last reported valuation was $14.4 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Calla Lily Clinical Care raised?

Calla Lily Clinical Care has raised $6.9 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Mar 2025.

Comparable companies

Comparable drug delivery names by valuation on PrivateMarketView: Terrestrial Bio ($96.1 million) and Zag Bio ($25 million).

How Calla Lily Clinical Care's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Calla Lily Clinical Care, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Calla Lily Clinical Care

What is Calla Lily Clinical Care worth?
Calla Lily Clinical Care is valued at $14.4M as of Oct 2026. Calla Lily Clinical Care's last reported valuation, Jan 2025. Nothing priced has surfaced since.
How much has Calla Lily Clinical Care raised?
Calla Lily Clinical Care has raised $6.9M in total funding across 1 recorded rounds.
When did Calla Lily Clinical Care last raise?
Calla Lily Clinical Care last raised in Mar 2025 (Accelerator/Incubator).